Stock screenerAll disclosures →
EDGAR →
URGN
Conviction 100HealthcareScan · Mon, Aug 10, 2026URGN$46.27-1.47%
ResistanceSupportVol 14Insider sellVol MA14 919.44K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price46.27
Change-1.47%
Gap-2.63%
Rel volume2.64×
Avg volume927.2K
Avg $ vol39.61M
SMA 2041.78
SMA 5036.50
SMA 20025.89
Price vs 50+26.77%
Price vs 200+78.75%
MA stackbullish
50/200 cross—
Supertrendup · 39.10
RSI (14)67
MACD hist0.33
MACD crossbull · 2d
Stoch %K / %D83 / 84
ADX (14)36
+DI / −DI30 / 13
RSI divergenceBearish
MACD divergenceBearish
ATR %+5.14%
ADR %5.42%
52w high46.96
52w low16.42
From 52w high-1.47%
Above 52w low+181.79%
New 52w highNo
SqueezeOff
Bollinger width24.82%
%B0.93
Donchian pos83.32%
Donchian high48.19
Donchian low36.68
AVWAP (52w high)46.47
vs AVWAP high-0.42%
AVWAP (52w low)25.59
vs AVWAP low+80.79%
OBV trendUp
Chaikin MF (20)-0.00
Today vs 20d2.64×
Avg vol (14d)919.43K
Avg vol (20d)927.2K
Avg $ vol (20d)39.61M
Market cap2.26B
RS 3m (vs SPY)+70.91%
RS 6m (vs SPY)+114.74%
RS line new highYes
Trend template8/8
Technical rank91.8
1 week+19.90%
1 month+19.99%
3 months+57.38%
6 months+116.72%
1 year+148.90%
YTD+103.74%
P/E-14.73
P/B-17.08
P/S20.60
P/FCF-13.90
EPS-4.96
Div yield—
ROE115.94%
ROA-60.77%
Debt/Eq-1.43
Current3.80
EV/EBITDA-19.04
Gross margin88.66%
Net margin-139.81%
Rev growth21.45%
EPS growth-20.98%
Price target57.33
Target upside23.90%
Analyst ratingBuy
Institutional97.57%
Ent. value2.37B
Revenue72.46M
Net income-14.35M
Gross profit65.88M
Free cash flow-162.73M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out48.72M
Employees291
ListedThu, May 4, 2017
Free float43.81M
Float %93.6%
Short interest5.69M
Days to cover6.9d
Short volume34.2%
Squeeze score66 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.28 vs −$0.38
Last surprise+26.3% beat
Setup gradeA+
Conviction100 / 100
Pattern quality—
Tech rank91.8 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance41.76
Support35.14
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in URGN
No recent disclosed trades by Congress in URGN. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in URGN · 5 buys · 5 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Schoenberg Mark Chief Medical Officer · Ordinary Shares · 2026-07-09 | Sell | 10K | $400K | 2026-07-09 | 2026-07-10 |
BUTITTA CYNTHIA M Director · Stock Option (right ot buy) · 2026-06-22 | Grant | 10K | — | 2026-06-22 | 2026-06-24 |
Belldegrun Arie Director · Stock Option (right ot buy) · 2026-06-22 | Grant | 20K | — | 2026-06-22 | 2026-06-24 |
BUTITTA CYNTHIA M Director · Restricted Stock Unit · 2026-06-22 | Grant | 8K | — | 2026-06-22 | 2026-06-24 |
Schoenberg Mark Chief Medical Officer · Ordinary Shares · 2026-06-08 | Exercise | 10K | — | 2026-06-08 | 2026-06-09 |
Schoenberg Mark Chief Medical Officer · Ordinary Shares · 2026-06-08 | Sell | 5.22K | $143K | 2026-06-08 | 2026-06-09 |
Schoenberg Mark Chief Medical Officer · Restricted Stock Units · 2026-06-08 | Exercise | 10K | $0 | 2026-06-08 | 2026-06-09 |
Robinson James A. Jr. Director · ordinary shares · 2026-05-26 | Exercise | 2K | — | 2026-05-26 | 2026-05-27 |
Robinson James A. Jr. Director · Restricted Stock Unit · 2026-05-26 | Exercise | 2K | $0 | 2026-05-26 | 2026-05-27 |
Schoenberg Mark Chief Medical Officer · Ordinary Shares · 2026-05-08 | Sell | 10K | $300K | 2026-05-08 | 2026-05-11 |
SEC filings
EDGAR filings in URGN · 7 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.